Mark Levine, SVP,GC & Sec at Minerva Neurosciences, holds 322.88K shares in Immunovant (Ticker: IMVT), holds 0.00 shares in Flexion Therapeutics (Ticker: FLXN), holds 0.00 shares in Minerva Neurosciences (Ticker: NERV). Most recently, Mark Levine Sold ― shares of Immunovant on Oct 25, 2024 for an estimated value of 128.78K.
What is the percentage of profitable transactions made by Mark Levine?
The percentage of profitable transactions made by Mark Levine is 44%.
What is the average return per transaction made by Mark Levine?
The average return per transaction made by Mark Levine is -13.70%.
What stocks does Mark Levine hold?
Mark Levine holds: NERV, FLXN, IMVT stocks.
What was Mark Levine’s latest transaction?
Mark Levine latest transaction was an Informative Sell of $128.78K.
What was Mark Levine's most profitable transaction?
Mark Levine’s most profitable transaction was an Informative Sell of IMVT stock on January 29, 2024. The return on the trade was 25.20%.
What is Mark Levine's role in Minerva Neurosciences?
Mark Levine's role in Minerva Neurosciences is SVP,GC & Sec.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.